Carboplatin Supplier-Buyer Network — Trade Flow Analysis

Name: Carboplatin Supplier-Buyer Trade Network Dataset — 273+ Indian Exporters, 23+ Importers, 138+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Carboplatin supplier network, Carboplatin buyers, pharmaceutical export India, Carboplatin trade data

TransData Nexus

Carboplatin

India Pharmaceutical Trade Intelligence

$70.9M273 Suppliers138 CountriesHS 30049047

ExportsIndia → GERMANY22.6%India → UNITED STATES17.1%

ImportsAUSTRALIA → India$1.1M SOUTH KOREA → India$89.3K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Who Supplies Carboplatin? Top Manufacturers & Buyers 2026 — FRESENIUS KABI ONCOLOGY LIMITED Leads | TransData Nexus | TransData Nexus

1FRESENIUS KABI ONCOLOGY LIMITED

FRESENIUS KABI ONCOLOGY LIMITED is the first-largest Carboplatin exporter from India, with a market share of 20.0% and a total export value of $14.1M across 735 shipments. Their average shipment value of $19.3K is below the market average of $19.5K, reflecting a high-volume, competitive pricing strategy.

FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 81.5% of this supplier's tracked business. Top customers include:

• FRESENIUS KABI DEUTSCHLAND GMBH — $11.5M across 599 shipments (81.5% of this supplier's total exports)

• FRESENIUS KABI COLOMBIA SAS — $750.8K across 39 shipments (5.3% of this supplier's total exports)

• FRESENIUS KABI THAILAND LTD — $651.7K across 34 shipments (4.6% of this supplier's total exports)

• FRESENIUS KABI THAILAND LTD — $613.0K across 32 shipments (4.3% of this supplier's total exports)

• FRESENIUS KABI MALAYSIA SDN BHD — $602.6K across 31 shipments (4.3% of this supplier's total exports)

Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (735 shipments) at a per-shipment value of $19.3K, indicating a broad distribution network with many smaller, regular orders.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Carboplatin exporter from India, with a market share of 8.7% and a total export value of $6.2M across 66 shipments. Their average shipment value of $93.9K is above the market average of $19.5K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. EUGIA US LLC, is the dominant customer, accounting for 50.7% of this supplier's tracked business. Top customers include:

• EUGIA US LLC, — $3.1M across 33 shipments (50.7% of this supplier's total exports)

• EUGIA US LLC, — $2.9M across 31 shipments (46.7% of this supplier's total exports)

• AUROVIDA FARMACEUTIC — $103.2K across 1 shipments (1.7% of this supplier's total exports)

• EUGAIA PHARMA SPECIA — $41.6K across 0 shipments (0.7% of this supplier's total exports)

• APL SWIFT SERVICES ( — $14.8K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $93.9K is 382% above the market average of $19.5K, consistent with large-order contracts or value-added formulations.

3GLAND PHARMA LIMITED

GLAND PHARMA LIMITED is the third-largest Carboplatin exporter from India, with a market share of 6.0% and a total export value of $4.3M across 10 shipments. Their average shipment value of $426.6K is above the market average of $19.5K, suggesting premium or bulk contract pricing.

GLAND PHARMA LIMITED serves 3 named buyers in our database. CHRIS LESSLY is the dominant customer, accounting for 57.9% of this supplier's tracked business. Top customers include:

• CHRIS LESSLY — $2.5M across 6 shipments (57.9% of this supplier's total exports)

• XXI LXXS LXX — $1.3M across 3 shipments (30.2% of this supplier's total exports)

• Nicole Salvi — $509.3K across 1 shipments (11.9% of this supplier's total exports)

Key Insight: GLAND PHARMA LIMITED's per-shipment value of $426.6K is 2088% above the market average of $19.5K, consistent with large-order contracts or value-added formulations.

4NV REMEDIES PRIVATE LIMITED

NV REMEDIES PRIVATE LIMITED is the fourth-largest Carboplatin exporter from India, with a market share of 4.1% and a total export value of $2.9M across 11 shipments. Their average shipment value of $264.4K is above the market average of $19.5K, suggesting premium or bulk contract pricing.

NV REMEDIES PRIVATE LIMITED serves 4 named buyers in our database. CPC "BIOCON" LLC is the dominant customer, accounting for 71.0% of this supplier's tracked business. Top customers include:

• CPC "BIOCON" LLC — $2.1M across 8 shipments (71.0% of this supplier's total exports)

• CPC "BIOCON" LLC — $817.5K across 3 shipments (28.1% of this supplier's total exports)

• CENTRE NATIONAL DE L — $26.7K across 0 shipments (0.9% of this supplier's total exports)

• MILI HEALTHCARE LTD — $21 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: NV REMEDIES PRIVATE LIMITED's per-shipment value of $264.4K is 1256% above the market average of $19.5K, consistent with large-order contracts or value-added formulations.

5INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the fifth-largest Carboplatin exporter from India, with a market share of 3.2% and a total export value of $2.3M across 190 shipments. Their average shipment value of $11.9K is below the market average of $19.5K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• XXCORXXHEAXXHCAXX INXX — $565.7K across 48 shipments (25.1% of this supplier's total exports)

• TO THE ORDER — $530.0K across 45 shipments (23.5% of this supplier's total exports)

• ACCORD HEALTHCARE INC — $401.2K across 34 shipments (17.8% of this supplier's total exports)

• XXCORXXHEAXXHCAXX LT — $380.4K across 32 shipments (16.9% of this supplier's total exports)

• ACCORD HEALTHCARE LI — $379.8K across 32 shipments (16.8% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (190 shipments) at a per-shipment value of $11.9K, indicating a broad distribution network with many smaller, regular orders.

6VENUS REMEDIES LIMITED

VENUS REMEDIES LIMITED is the fifth-largest Carboplatin exporter from India, with a market share of 1.9% and a total export value of $1.4M across 123 shipments. Their average shipment value of $11.0K is below the market average of $19.5K, reflecting a high-volume, competitive pricing strategy.

VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• E M I — $544.1K across 49 shipments (40.2% of this supplier's total exports)

• A.S.A.S — $460.7K across 42 shipments (34.0% of this supplier's total exports)

• IMS PHARMA PNA — $144.2K across 13 shipments (10.6% of this supplier's total exports)

• B P D & C C — $112.1K across 10 shipments (8.3% of this supplier's total exports)

• A S A S ALPHARMA SAS — $92.8K across 8 shipments (6.9% of this supplier's total exports)

Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (123 shipments) at a per-shipment value of $11.0K, indicating a broad distribution network with many smaller, regular orders.

1Germany

Germany ranks as the first-largest destination for Carboplatin imports from India, with a total trade value of $16.0M across 391 shipments — representing a 22.6% share of all Carboplatin exports. The average shipment value of $40.9K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carboplatin importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 99.3% ($15.9M) of this market's total imports.

• FRESENIUS KABI DEUTSCHLAND GMBH — $15.9M (99.3% of Germany's total)

Key Insight: Germany's per-shipment average of $40.9K (110% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Carboplatin imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Carboplatin imports from India, with a total trade value of $12.2M across 65 shipments — representing a 17.1% share of all Carboplatin exports. The average shipment value of $187.0K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Carboplatin importers in United States: EUGIA US LLC is the largest buyer, accounting for 27.8% ($3.4M) of this market's total imports.

• EUGIA US LLC — $3.4M (27.8% of United States's total)

• EUGIA US LLC, — $3.3M (27.0% of United States's total)

• CHRIS LESSLY — $2.5M (20.3% of United States's total)

Key Insight: United States's per-shipment average of $187.0K (859% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Carboplatin imports from India.

Primary Market

Secondary Market

3Thailand

Thailand ranks as the third-largest destination for Carboplatin imports from India, with a total trade value of $4.8M across 24 shipments — representing a 6.8% share of all Carboplatin exports. The average shipment value of $199.5K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Carboplatin importers in Thailand: FRESENIUS KABI (THAILAND) LTD is the largest buyer, accounting for 23.6% ($1.1M) of this market's total imports.

• FRESENIUS KABI (THAILAND) LTD — $1.1M (23.6% of Thailand's total)

• FRESENIUS KABI (THAILAND) LTD., — $701.9K (14.7% of Thailand's total)

• FRESENIUS KABI THAILAND LTD — $651.7K (13.6% of Thailand's total)

Key Insight: Thailand's per-shipment average of $199.5K (923% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Carboplatin imports from India.

Primary Market

Secondary Market

4Philippines

Philippines ranks as the fourth-largest destination for Carboplatin imports from India, with a total trade value of $3.2M across 16 shipments — representing a 4.6% share of all Carboplatin exports. The average shipment value of $202.7K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carboplatin importers in Philippines: MULTICARE PHARMACEUTICALS PHILIPPIN is the largest buyer, accounting for 24.3% ($786.8K) of this market's total imports.

• MULTICARE PHARMACEUTICALS PHILIPPIN — $786.8K (24.3% of Philippines's total)

Key Insight: Philippines's per-shipment average of $202.7K (940% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Carboplatin imports from India.

Primary Market

Secondary Market

5Ukraine

Ukraine ranks as the fifth-largest destination for Carboplatin imports from India, with a total trade value of $2.9M across 7 shipments — representing a 4.1% share of all Carboplatin exports. The average shipment value of $415.7K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Carboplatin importers in Ukraine: CPC "BIOCON" LLC is the largest buyer, accounting for 70.9% ($2.1M) of this market's total imports.

• CPC "BIOCON" LLC — $2.1M (70.9% of Ukraine's total)

• CPC BIOCON LLC — $817.5K (28.1% of Ukraine's total)

Key Insight: Ukraine's per-shipment average of $415.7K (2032% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ukraine is a key market for Carboplatin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Carboplatin.
2.Flow Mapping: 273 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,637 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 138 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,637 Verified Shipments

273 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Carboplatin

Carboplatin

Who Supplies Carboplatin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Carboplatin — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Carboplatin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Carboplatin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1FRESENIUS KABI ONCOLOGY LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3GLAND PHARMA LIMITED

4NV REMEDIES PRIVATE LIMITED

5INTAS PHARMACEUTICALS LIMITED

6VENUS REMEDIES LIMITED

From Indian Factories to Global Pharmacies — How Carboplatin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Carboplatin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Germany

2United States

3Thailand

4Philippines

5Ukraine

People Also Ask — Carboplatin Supplier & Trade Network

Carboplatin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology